Viewing Study NCT05253833


Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2026-01-25 @ 12:39 AM
Study NCT ID: NCT05253833
Status: COMPLETED
Last Update Posted: 2025-01-29
First Post: 2022-02-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout
Sponsor: Arthrosi Therapeutics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gout View
None Arthritis, Gouty View
None Hyperuricemia View
None Gout Chronic View
Keywords: